Ruyi received a BS in chemistry from Peking University. He is currently pursuing a PhD in chemistry at UChicago.
Ruyi's project is focused on the combination of chemotherapy and immunotherapy. To be specific, he uses block copolymers to deliver either chemotherapeutic drugs or immunomodulators to different target cells.
